Share
Miss Kehinde Mary Adeyemi, a 500-level student of the Ladoke Akintola University of Technology (LAUTECH) Ogbomoso, was among the young ladies who participated in the recently concluded Miss Oyo 2020. Though she didn’t win the main crown, she emerged as Oyo States’s Miss Elegant among the 21 participants at the beauty pageant. The student of Anatomy who combines beauty, brain, and elegance speaks about her experience, passion, and advice for aspiring beauty queens in this interview.
What led to your interest in participating in a beauty pageant, considering that you are a science student?
As a young lady, I have always developed an interest in fashion, modeling, and looking good all the time. I like taking pictures and always looking good at all times with the right colours and shoes to match. So it was easy for me to pick from this while growing up.
Punch Newspapers
Sections
Background
I am 24 years old and a daughter to the Alaafin of Oyo, Oba Lamidi Adeyemi. I am enthusiastic about African culture and domestic tourism. I run a blog where I showcase and promote African heritage. I am also the co-founder of a non-governmental organisation, Adeyemi Sisters Special Foundation. I am the Vice-President of the Yoruba Tourism Forum as well. I like activism and human rights too. During my undergraduate days, I was a unionist. I was the social secretary of the National Association of Oyo Students, and the vice-president of the History and International Studies Student Association at Osun State University in 2015 and 2016 respectively.
COVID-19 vaccine: NAFDAC rules out clinical trial
• Reps set to revisit bill mandating vaccines for Nigerians
• FG places six-month ban on 100 travellers for shunning PCR test
• Bayelsa, Ebonyi postpone school resumption, Rivers resumes Monday
Our Reporters
The National Agency for Food and Drug Administration and Control has ruled out the possibility of conducting a local clinical trial on the proposed N400bn vaccines before administering them on Nigerians.
The agency said since the World Health Organisation had approved the vaccines there might not be need to conduct another clinical trial on the vaccines.
It, however, said it would subject vaccines, which the Federal Government may likely spend N400bn to procure, to proper revalidation before administering them on Nigerians.